Long-term complete remission in IgD-myeloma

European Journal of Haematology

Volumn 76, Issue 4, 2006, Pages 339-341

  Bemelmans, R H H ^a   Van Toorn, D W ^a   Van Leeuwen, L ^a   Schaar, C G ^a  

^a GELRE HOSPITALS   (Netherlands)

Author keywords

Complete remission; IgD multiple myeloma; Long term remission

Indexed keywords

IMMUNOGLOBULIN D; MELPHALAN; PAMIDRONIC ACID; PREDNISONE;

AGED; ANAMNESIS; ARTICLE; BONE LESION; BONE MARROW EXAMINATION; BONE RADIOGRAPHY; CANCER CHEMOTHERAPY; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LABORATORY TEST; MALE; MYELOMA; OSTEOPOROSIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REMISSION;

AGED; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; BONE MARROW CELLS; HUMANS; IMMUNOGLOBULIN D; MALE; MELPHALAN; MULTIPLE MYELOMA; PREDNISONE; REMISSION INDUCTION;

EID: 33644847638     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2005.00600.x     Document Type: Article

References (12)

1. B lade J K yle RA. Nonsecretory myeloma, immunoglobulin d myeloma, and plasma cell leukemia Hematol Oncol Clin North Am 1999 13 1259 1272
2. S inclair D. IgD myeloma: clinical, biological and laboratory features Clin Lab 2002 48 617 622
3. R owe DS F ahey JL. A new class of human immunoglobulins. I. A unique myeloma protein J Exp Med 1965 121 171 184
4. B lade J L ust JA K yle RA. I mmunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 cases J Clin Oncol 1994 12 2398 2404
5. S himamoto Y A nami Y Y amaguchi M. A new risk grouping for IgD myeloma based on analysis of 165 japanese patients Eur J Haematol 1991 47 262 267
6. D urie BG S almon SE. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival Cancer 1975 36 842 854
7. K yle RA. IgD multiple myeloma: a cure at 21 years Am J Hematol 1988 29 41 43
8. H iyoshi M H ashimoto S O ta T N akao T T akubo T T agawa S T atsumi N. Long-term survival in a case of high-risk type IgD myeloma; a possibility of effectiveness of interferon-alpha and erythropoietin Haematologia (Budap) 1997 28 177 180
9. W echalekar A A mato D C hen C K eith SA R eece D. IgD multiple myeloma-a clinical profile and outcome with chemotherapy and autologous stem cell transplantation Ann Hematol 2005 84 115 117
10. G reipp PR S an Miguel J D urie BGM et al. International staging system for multiple myeloma J Clin Oncol 2005 23 3412 3420
11. S chaar CG K luin -N elemans JC L e CS F ranck PF te M arvelde MC W ijermans PW. Early response to therapy and survival in multiple myeloma Br J Haematol 2004 125 162 166
12. B arlogie B. High-dose therapy and innovative approaches to treatment of multiple myeloma Semin Hematol 2001 38 21 27